Studies of the expression of the Wiskott-Aldrich syndrome protein

Journal of Clinical Investigation

Volumn 97, Issue 11, 1996, Pages 2627-2634

  Stewart, Donn M ^a   Treiber Held, Stephanie ^a   Kurman, Carole C ^a   Facchetti, Fabio ^b   Notarangelo, Luigi D ^b   Nelson, David L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

antibodies, monoclonal; immunoblotting; immunodeficiency, congenital; immunohistochemistry; mutation

Indexed keywords

HYBRID PROTEIN; MONOCLONAL ANTIBODY; PROTEIN; RNA; UNCLASSIFIED DRUG; WISKOTT ALDRICH SYNDROME PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CASE REPORT; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; DNA SEQUENCE; ECZEMA; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYBRIDOMA; IMMUNOBLOTTING; LYMPHOPROLIFERATIVE DISEASE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RNA SEQUENCE; SPLEEN; T LYMPHOCYTE; THROMBOCYTE; THROMBOCYTOPENIA; WISKOTT ALDRICH SYNDROME;

EID: 0029982620     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118712     Document Type: Article

References (42)

1. Aldrich, R.A., A.G. Steinberg, and D.C. Campbell. 1954. Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea. Pediatrics. 13:133-138.
2. Rosen, F.S., M.D. Cooper, and M.D. Wedgwood. 1995. The primary immunodeficiencies. N. Engl. J. Med. 333:431-440.
3. Derry, J.M.J., H.D. Ochs, and U. Francke. 1994. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell. 78:635-644.
4. Derry, J.M.J., H.D. Ochs, and U. Francke. 1994. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell. 79:923. Published Erratum.
5. Kwan, S., T.L. Hagemann, B.E. Radtke, R.M. Blaese, and F.S. Rosen. 1995. Identification of mutations in the Wiskott-Aldrich syndrome gene and characterization of a polymorphic dinucleotide repeat at DXS6940, adjacent to the disease gene. Proc. Natl. Acad. Sci. USA. 92:4706-4710.
6. Kolluri, R., A. Shehabedin, M. Peacocke, A. Lamhonwah, K. Teichert-Kuliszewska, S.M. Weissman, and K. Siminovitch. 1995. Identification of WASP mutations in patients with Wiskott-Aldrich syndrome and isolated thrombocytopenia reveals allelic heterogeneity at the WAS locus. Hum. Mol. Genet. 4:1119-1126.
7. Derry, J., J. Kerns, K. Weinberg, H. Ochs, V. Volpini, X. Estivill, A.P. Walker, and U. Franke. 1995. WASP gene mutations in the Wiskott-Aldrich syndrome and X-linked thrombocytopenia. Hum. Mol. Genet. 4:1127-1135.
8. Villa, A., L. Notarangelo, P. Macchi, E. Mantuano, G. Cavagni, D. Brugnoni, D. Strina, M. Patrosso, U. Ramengni, M. Sacco, A. Ugazio, and P. Vezzoni. 1995. X-linked thrombocytopenia and Wiskott-Aldrich syndrome are alleleic diseases with mutations in the WASP gene. Nat. Genet. 9:414-417.
9. Wengler, G.S., L.D. Notarangelo, S. Berardelli, G. Pollonni, P. Mella, A. Fasth, A.G. Ugazio, and O. Parolini. 1995. High prevalence of nonsense, frame shift, and splice-site mutations in 16 patients with full-blown Wiskott-Aldrich syndrome. Blood. 86:3648-3654.
10. Nelson, D.L., B.M. Bundy, H.E. Pitchon, R.M. Blaese, and W. Strober. 1976. The effector cells in human peripheral blood mediating mitogen-induced cellular cytotoxicity and antibody-dependent cellular cytotoxicity. J. Immunol. 117:1472-1481.
11. Frorath, B., C.C. Abney, H. Berthold, M. Scanarine, and W. Northemann. 1992. Production of recombinant rat interleukin-6 in Escherichia coli using a novel highly efficient expression vector pGEX-3T. Biotechniques. 12:558-563.
12. Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72:248-254.
13. Fuller, S.A., M.J. Takhashi, and J.G.R. Hurrell. 1988. Fusion of myeloma cells with immune spleen cells. In Current Protocols in Molecular Biology, F.M. Ausubel, R. Brent, R.E. Kingston, D.D. Moore, J.A. Smith, J.G. Seiddman, and K. Struhl, editors. Green Publishing Associates and Wiley-Interscience, New York. 11-7-1-11-7-4.
14. Stewart, D.M., C.C. Kurman, and D.L. Nelson. 1995. Production of monoclonal antibodies to Bruton's tyrosine kinase. Hybridoma. 14:243-246.
15. Corash L, H. Tan, and H.R. Gralnick. 1977. Heterogeneity of human whole blood platelet subpopulations. I. Relationship between buoyant density, cell volume and ultrastructure. Blood. 49:71-87.
16. Bock, G.H., C.M. Long, M.L. Riley, J.D. White, C.C. Kurman, T.A. Fleisher, M. Tsokos, M. Brown, D. Serbousek, W.D. Schwieterman, and D.L. Nelson. 1993. Characterization of a new IL-6 dependent human B-lymphoma cell line in long term culture. Cytokine. 5:480-489.
17. Yarchoan, R., G. Tosato, R.M. Blaese, R.M. Simon, and D.L. Nelson. 1983. Limiting dilution analysis of Epstein-Barr virus-induced immunoglobulin production by human B cells. J. Exp. Med. 157:1-14.
18. Gallagher, S., S.E. Winston, S.A. Fuller, and J.G.R. Hurrell. 1993. Immunoblotting and immunodetection. In Current Protocols in Molecular Biology, F.M. Ausubel, R. Brent, R.E. Kingston, D.D. Moore, J.A. Smith, J.G. Seidman, and K. Struhl, editors. Green Publishing and Wiley Interscience, New York. 10-8-1.
19. Selden, R.F. 1989. Analysis of RNA by Northern hybridization. In Current Protocols in Molecular Biology, F.M. Ausubel, R. Brent, R.E. Kingston, D.D. Moore, J.A. Smith, J.G. Seidman, and K. Struhl, editors. Green Publishing and Wiley Interscience, New York. 4-9-1.
20. Bergstrom, C.P., C.R. Wagner, D.K. Ann, and P.E. Hanna. 1995. Hamster monomorphic arylamine N-acetyltransferase: expression in Escherichia coli and purification. Protein Expr. Purif. 6:45-55.
21. Rabinovsky, E.D., D.P. Browder, and J.L. McManaman. 1994. Preparation and affinity purification of a novel, biologically active, CNTF fusion protein. Biochem. J. 305:753-759.
22. Baldini, M.G. 1972. Nature of the platelet defect in the Wiskott-Aldrich syndrome. Ann. NY Acad. Sci. 201:437-444.
23. Murphy, S., F.A. Oski, J.L. Naiman, C.J. Lusch, S. Goldberg, and F.H. Gardener. 1972. Platelet size and kinetics in hereditary and acquired thrombocytopenia. N. Engl. J. Med. 286:499-504.
24. Ochs, H.D., S.J. Slichter, L.A. Harker, W.E. Von Behrens, R.A. Clark, and R.J. Wedgewood. 1980. The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes and platelets. Blood. 55:243-252.
25. Cooper, M.S., H.P. Chase, J.T. Lowman, W. Krivit, and R.A. Good. 1968. Wiskott-Aldrich syndrome: an immunologic deficiency disease involving the afferent limb of immunity. Am. J. Med. 44:499-513.
26. Blaese, R.M., W. Strober, R.S. Brown, and T.A. Waldmann. 1968. The Wiskott-Aldrich syndrome: a disorder with a possible defect in antigen processing or recognition. Lancet. i:1056-1061.
27. Oppenheim, J.J., R.M. Blaese, and T.A. Waldmann. 1970. Defective lymphocyte transformation and delayed hypersensitivity in Wiskott-Aldrich syndrome. J. Immunol. 104:835-844.
28. Molina, I.L., D.M. Kenney, F.S. Rosen, and E. Remold-O'Donnell. 1992. T cell lines characterize events in the pathogenesis of the Wiskott-Aldrich syndrome. J. Exp. Med. 176:867-874.
29. Molina, I.J., J. Sancho, C. Terhorst, F. S. Rosen, and I. Remold-O'Donnell. 1993. T cells of patients with the Wiskott-Aldrich syndrome have a restricted defect in proliferative responses. J. Immunol. 151:4383-4390.
30. Parkman, R., E. Remold-O'Donnell, D.M. Kenney, S. Perrine, and F.S. Rosen. 1981. Surface protein abnormalities in lymphocytes and platelets from patients with Wiskott-Aldrich syndrome. Lancet. ii:1387-1389.
31. Remold-O'Donnell, E., and F.S. Rosen. 1990. Sialophorin (CD43) and the Wiskott-Aldrich syndrome. 1990. Immunodef. Rev. 2:151-174.
32. Piller, F., F. Le Deist, K.I. Weinberg, R. Parkman, and M. Fukuda. 1991. Altered O-glycan synthesis in lymphocytes from patients with Wiskott-Aldrich syndrome. J. Exp. Med. 173:1501-1510.
33. Higgins, E.A., K.A. Siminovitch, D. Zhuang, I. Brockhausen, and J.W. Dennis. 1991. Aberrant O-linked oligosaccharide biosynthesis in lymphocytes and platelets from patients with the Wiskott-Aldrich syndrome. J. Biol. Chem. 266:6280-6290.
34. Greer, W.L., E. Higgins, D.R. Sutherland, A. Novogrodsky, I. Brockhausen, M. Peacocke, L.A. Rubin, M. Baker, J.W. Dennis, and K.A. Siminovitch. 1989. Altered expression of leucocyte sialoglycoprotein in Wiskott-Aldrich syndrome is associated with a specific defect in O-glycosylation. Biochem. Cell Biol. 67:503-509.
35. Simon, H., G.B. Mills, S. Hashimoto, and K.A. Siminovitch. 1992. Evidence for defective transmembrane signaling in B cells from patients with Wiskott-Aldrich syndrome. J. Clin. Invest. 90:1396-1405.
36. Poplack, D.G., G.D. Bonnard, B.J. Holiman, and R.M. Blaese. 1976. Monocyte-mediated antibody-dependent cellular cytotoxicity: a clinical test of monocyte function. Blood. 48:809-816.
37. Rivero-Lezcano, O.M., A. Marcilla, J.H. Smeshima, and K.C. Robbins. 1995. Wiskott-Aldrich syndrome protein physically associates with Nck through Src homology 3 domains. Mol. Cell. Biol. 15:5725-5731.
38. Aldovini, A., C. Debouck, M.B. Feinberg, M. Rosenberg, S.K. Arya, and F. Wong-Staal. 1986. Synthesis of the complete trans-activation gene product of human T-lymphocyte virus type III in Escherichia coli: demonstration of immunogenicity in vivo and expression in vitro. Proc. Natl. Acad. Sci. USA. 83: 6672-6676.
39. Ferguson, B., N. Jones, J. Richter, and M. Rosenberg. 1984. Adenovirus E1a gene product expressed at high levels in Escherichia coli is functional. Science (Wash. DC). 224:1343-1346.
40. Van Beveren, C., F. van Straaten, T. Curran, R. Müller, and I.M. Verma. 1983. Analysis of FBJ-MuSV provirus and c-fos (mouse) gene reveals that viral and cellular fos gene products have different carboxy termini. Cell. 32: 1241-1255.
41. Watt, R.A., A.P. Shatzman, and M. Rosenberg. 1985. Expression and characterization of the human c-myc DNA-binding protein. Mol. Cell. Biol. 5: 448-456.
42. Simpson, S.B, and C.M. Stoltsfus. 1994. Frameshift mutations in the v-src gene of avian sarcoma virus act in cis to specifically reduce v-src mRNA levels. Mol. Cell. Biol. 14:1835-1844.